 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Recommend company
|
300 Technology Square 02139 Cambridge, MA
United States of America
|
|
Portrait Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development.
Dyax is headquartered in Cambridge, Massachusetts, and has antibody discovery facilities in Liege, Belgium.
Industrial Sectors
Additional information
Dyax Corp. Cambridge, MA, United States of America
News
|
|
|
|
|
|